EP 1183023 A1 20020306 - USE OF VERAPAMIL AND VERAPAMIL DERIVATIVES FOR PRODUCING MEDICAMENTS WITH AN INHIBITING EFFECT ON BETA-GLUCURONIDASE IN HUMAN TISSUE
Title (en)
USE OF VERAPAMIL AND VERAPAMIL DERIVATIVES FOR PRODUCING MEDICAMENTS WITH AN INHIBITING EFFECT ON BETA-GLUCURONIDASE IN HUMAN TISSUE
Title (de)
VERWENDUNG VON VERAPAMIL UND VERAPAMILDERIVATEN ZUR HERSTELLUNG VON ARZNEIMITTELN MIT BETA-GLUCURONIDASE IM HUMANEN GEWEBE HEMMENDER WIRKUNG
Title (fr)
UTILISATION DE VERAPAMIL ET DE DERIVES DE VERAPAMIL POUR LA PRODUCTION DE MEDICAMENTS AYANT UN EFFET INHIBITEUR SUR LA BETA-GLUCURONIDASE DANS UN TISSU HUMAIN
Publication
Application
Priority
- DE 19925810 A 19990607
- EP 0004848 W 20000527
Abstract (en)
[origin: DE19925810A1] The invention relates to the use of verapamil or verapamil derivatives for producing medicaments which have an inhibiting effect on beta -glucuronidase in human tissue.
IPC 1-7
IPC 8 full level
A61K 31/275 (2006.01); A61K 31/277 (2006.01); A61K 47/42 (2006.01); A61P 1/00 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 31/275 (2013.01); A61K 31/277 (2013.01); A61P 1/00 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 0074670A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
DE 19925810 A1 20001214; CA 2376199 A1 20001214; EP 1183023 A1 20020306; JP 2003501384 A 20030114; WO 0074670 A1 20001214
DOCDB simple family (application)
DE 19925810 A 19990607; CA 2376199 A 20000527; EP 0004848 W 20000527; EP 00931265 A 20000527; JP 2001501207 A 20000527